Medical Journals

Fucoxanthin and Fucoxanthinol Enhance the Amount of Docosahexaenoic Acid in the Liver of Kkay Obese/Diabetic Mice.

Authors:
  • Tsukui Takayuki
  • Konno Kensuke
  • Hosokawa Masashi
  • Maeda Hayato
  • Sashima Tokutake
  • Miyashita Kazuo

From: Faculty of Fisheries Sciences and Creative Research Institute, Hokkaido University, Hakodate, Hokkaido 041-8611, Japan.

Journal of agricultural and food chemistry

  • Publish Date: Jun 2007
  • ISSN: 0021-8561
  • Volume: 55
  • Issue: 13
  • Pages: 5025-9
  • Medium: Print
  • Language: English
  • Citation (JAMA): Tsukui Takayuki, Konno Kensuke, Hosokawa Masashi, et al. Fucoxanthin and Fucoxanthinol Enhance the Amount of Docosahexaenoic Acid in the Liver of Kkay Obese/Diabetic Mice.. J. Agric. Food Chem. Jun 2007;55:5025-9

Abstract

This study examined the effect of dietary fucoxanthin or fucoxanthinol on the amount of docosahexaenoic acid (DHA) in the liver of KKAy mice, a model for obese/type II diabetes. In the first experiment, mice were fed diets containing crude fucoxanthin or glyceroglycolipid for 4 weeks. Results showed a significant increase in the level of DHA in mice fed 0.53% crude fucoxanthin, from 2.3% in control mice to 5.1% of fatty acid composition of total liver lipids. On the other hand, in mice fed crude glyceroglycolipid, the level of DHA as a proportion of total liver fatty acids remained unchanged. To clarify the enhancement of hepatic DHA, in the second experiment, KKAy mice were fed a diet containing purified fucoxanthin or its deacetylated derivative, fucoxanthinol. Results from a quantitative analysis using an internal standard showed that in mice fed 0.2% fucoxanthin, the amount of hepatic DHA was 2-fold higher than in control mice, whereas DHA levels in the small intestine remained unchanged. Furthermore, 0.2% fucoxanthinol led to 1.8- and 1.2-fold increases in the amount of hepatic DHA and arachidonic acid compared to control mice, respectively. These results indicate for the first time that dietary fucoxanthin and fucoxanthinol enhance the amount of DHA in the liver of KKAy mice.

Mesh Headings (Keywords): Animals, Diabetes Mellitus, Type 2, Diet, Docosahexaenoic Acids, Female, Liver, Mice, Obesity, Xanthophylls, beta Carotene


Check for Full Text / PubMed Unique Identifier (PMID): 17536824


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.